您的位置：
首页
>
农业专利
>
详情页
ANTICORPS LIANT ET BLOQUANT UN RÉCEPTEUR DE DÉCLENCHEMENT EXPRIMÉ SUR DES CELLULES-1 MYÉLOÏDES (TREM-1)
专利权人:
NOVO NORDISK A/S
发明人:
申请号：
EP19182096.8
公开号：
EP3611190A1
申请日:
2012.11.30
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
There is provided antibodies that are capable of specifically binding TREM-1 and preventing the activation of TREM-1, a protein expressed on monocytes, macrophages, and neutrophils. Such antibodies find utility in the treatment of individuals with an inflammatory disease.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
Способ диагностики клеточных иммунопатологий человека
Derivation of unlimited quantities of neutrophils or monocyte/dendritic cells
hematopoietic stem cell, hematopoietic progenitor cell, myeloid / monocyte-compromised progenitor cell, macrophage or monocyte, tumor-associated antigen-specific t cell, immune checkpoint inhibitor, 1-methyl-tryptophan, combination of a point inhibitor of immune check and a specific t-cell for tumor-associated antigen, method for treating or preventing cancer, and population of hematopoietic stem cells, hematopoietic progenitor cells, myeloid / monocyte-compromised progenitor cells, macrophages or monocytes.
THÉRAPIE GÉNIQUE
STEM CELL FOR THERAPEUTIC USE WHICH IS DERIVED FROM HUMAN MONOCYTE, AND METHOD FOR INDUCING SAME
